Histiocytosis

Histiocytosis is a general term for a group of rare diseases. These diseases involve an abnormal increase in a type of immune cell called histiocytes. These cells are normally found in tissues throughout the body, including the skin, lungs, liver, and spleen. The diseases can affect different parts of the body or the whole body.

Condition

What people with Histiocytosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Vinblastine for Histiocytosis?

NameHow it went

About Histiocytosis

What It Is

Histiocytosis is the name for a group of rare disorders in which histiocytes, immune cells that normally clear away germs and debris, build up in places they should not. The excess cells can form lesions in bone, skin, lymph nodes or internal organs, or drive inflammation that damages tissue. More than 100 subtypes have been described in children and adults, and they range from a single bone spot that heals on its own to illnesses that threaten life. Because the label covers such different diseases, the specific type matters more than the umbrella name. Langerhans cell histiocytosis (LCH) is the best known: it most often affects a single bone, but it can also involve the skin, lungs, pituitary gland or several organs at once. Other members of the group include Erdheim-Chester disease, a slow-growing disorder usually found in adults between 40 and 60; Rosai-Dorfman disease, which is usually benign and often appears as enlarged lymph nodes in the neck; and hemophagocytic lymphohistiocytosis (HLH), a sudden and dangerous overreaction of the immune system.

Causes & Risk Factors

Many histiocytoses are now understood to start with changes (mutations) in genes that control cell growth signals, such as the BRAF gene. These changes arise in the affected cells during life and are not usually inherited. In LCH and Erdheim-Chester disease, they push histiocytes to multiply and gather in tissues, which is why doctors who treat cancer usually manage these conditions, even though it is still debated whether LCH is a true cancer. Researchers have found associations rather than clear causes. For LCH, these include a family history of LCH or cancer, a parent's workplace exposure to solvents or metal, wood or granite dust, and infections in the newborn period. In adults, LCH limited to the lungs is strongly linked to smoking. HLH is different: the familial form is caused by inherited gene variants and usually appears in infancy, often set off by an infection, while other cases arise in older children and adults alongside infections, cancers or autoimmune disease. None of these factors means a person or parent caused the illness.

How It's Diagnosed

Histiocytosis is usually suspected from where symptoms appear: a painful lump on the skull or another bone, a stubborn scaly rash that resembles cradle cap or dandruff, swollen gums, enlarged lymph nodes, lung symptoms in a smoker, or unexplained thirst and frequent urination. Diagnosis rests on a biopsy, in which a small piece of the affected tissue is removed and a pathologist examines it under a microscope with special stains that identify the type of histiocyte. The sample is often tested for gene changes such as BRAF, which can guide treatment. Once the type is known, doctors look for every site the disease involves, because that decides the treatment. This usually means blood counts and liver tests, urine tests, and imaging such as x-rays of the skeleton, a PET or CT scan, or an MRI of the brain and pituitary gland. Lung function tests are used when the lungs are involved. HLH is diagnosed differently, from a pattern of fever, an enlarged spleen, low blood counts and specific blood markers, sometimes with a bone marrow sample and genetic testing.

Treatment Options

Treatment depends on the type of histiocytosis and on which organs are affected. In LCH, disease in the skin, bone, lymph nodes or pituitary gland is called low risk and usually responds well; involvement of the liver, spleen or bone marrow is called high risk, is harder to treat and is seen mostly in children under 2. A single bone lesion may need only a biopsy, scraping of the lesion (curettage) or close observation, and some skin-only LCH in infants clears without treatment. Lesions in several places or in risk organs are usually treated with chemotherapy, often given with a steroid over many months. Light-based therapy or creams may be used for the skin, and low-dose radiation is occasionally used for a lesion pressing on nearby structures. Targeted medicines have changed care for many people whose disease carries a BRAF or related gene change. They block the overactive growth signal and are taken as tablets. Vemurafenib (Zelboraf), a BRAF inhibitor, is approved for Erdheim-Chester disease with a BRAF V600 mutation, and cobimetinib (Cotellic), a MEK inhibitor, is approved for adults with histiocytic neoplasms. These drugs can control disease that did not respond to chemotherapy, but symptoms can return when they are stopped, so treatment is often long-term, and side effects need regular checks of the skin, eyes and heart. For adults with lung LCH, stopping smoking is the most important step, since lung damage tends to worsen in people who keep smoking. HLH is treated urgently in hospital with medicines that calm the immune response, and the familial form usually needs a stem cell transplant. Because these conditions are rare, care is best planned with a team experienced in histiocytic disorders, and clinical trials are often an option.

What to Expect

The course varies widely by type. Many people with single-site LCH, especially in bone, recover fully. Multisystem LCH can need months of treatment, and it can come back after treatment ends, usually in bone, skin or the pituitary gland, so regular checkups continue for years. Some effects can last after the disease is controlled, caused either by the histiocytosis or its treatment. In LCH these include diabetes insipidus (a hormone problem that causes heavy thirst and urination and is managed with a replacement hormone), slowed growth or other hormone changes, hearing loss, bone or tooth problems, lung scarring, and, rarely, a gradual brain condition that affects balance, coordination, learning or behavior. Long-term follow-up is meant to catch these early. Erdheim-Chester disease is usually a chronic illness managed over years with ongoing targeted therapy and checks of the heart, kidneys and brain. Living with a rare disease can also mean traveling to specialist centers, and patient groups focused on histiocytosis can help families find experienced doctors.

When to Seek Help

See a doctor about a bone lump or pain that does not settle, a scaly or crusted rash that keeps returning despite usual treatment, persistent swollen gums or loose teeth, or new extreme thirst and frequent urination. Anyone treated for histiocytosis should report returning pain, rash or thirst, or signs of hormone changes such as slowed growth, so recurrence can be checked. Contact the care team right away for a persistent high fever with easy bruising or bleeding, yellowing of the skin or eyes, a swelling abdomen or repeated infections, since these can signal involvement of the liver, spleen or bone marrow, or HLH. For anyone receiving chemotherapy or other treatment that lowers blood counts, any fever needs a call to the care team right away, because low white cell counts make infection dangerous. In someone with lung LCH, sudden chest pain with trouble breathing can mean a collapsed lung and needs immediate emergency care.

Questions to Ask Your Doctor

  1. 1.Which type of histiocytosis is this, and which parts of the body are affected?
  2. 2.Does the biopsy show a BRAF or other gene change, and does that open up targeted treatment?
  3. 3.What are the realistic goals and side effects of the treatment you recommend, and how long would it last?
  4. 4.What follow-up tests will we need, and for how many years, to watch for recurrence or late effects?
  5. 5.Is there a specialist center or clinical trial we should consider for this condition?

Last reviewed • Oct 2026

Educational content, not medical advice.